No Data
No Data
Shenyang Xingqi Pharmaceutical (300573.SZ): All production lines of the company have passed GMP certification.
Shenyang Xingqi Pharmaceutical (300573.SZ) stated on the investor interaction platform on August 16 that all production lines of the company have passed the GMP certification, and the company will arrange production according to the production and operation plan.
Shenyang Xingqi Pharmaceutical (300573.SZ): Low concentration atropine eye drops have reached cooperation with many domestic private chain medical institutions, including Aier Eye Hospital Group.
Shenyang Xingqi Pharmaceutical (300573.SZ) stated on the investor interactive platform on August 16th that the company's low-concentration atropine eye drops have reached cooperation with multiple private chain medical institutions in China, including Aier Eye Hospital Group.
Shenyang Xingqi Pharmaceutical (300573.SZ): Currently, the company has no new coronavirus prevention and treatment drugs.
Shenyang Xingqi Pharmaceutical (300573.SZ) stated on the investor interaction platform on August 12th that the company currently has no COVID-19 prevention and treatment drugs.
Shenyang Xingqi Pharmaceutical (300573.SZ): In 2023, the company was awarded the title of "Provincial Green Factory" and passed the evaluation and acceptance of "Zero Waste Factory".
On August 9th, Gelon Hui Corporation reported on its investor interaction platform that Shenyang Xingqi Pharmaceutical actively practices a green low-carbon strategy, introduces innovative technologies to improve its green operation level, and reduces the impact of its business operations on the environment. In 2023, the company won the title of "Provincial Green Factory" and passed the "Zero Waste Factory" appraisal and acceptance. The company fully implements the relevant regulations of the green factory, focuses on building a green supply chain, realizes the full chain digital transformation from R&D to packaging, and continuously accelerates the pace of green and low-carbon transformation, jointly promoting the industry's green and high-quality development. In the future, the company will continue to practice the ESG development concept and promote
With A 25% Price Drop For Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) You'll Still Get What You Pay For
Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
No Data